Paul Salm

1.1k total citations
34 papers, 869 citations indexed

About

Paul Salm is a scholar working on Transplantation, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Paul Salm has authored 34 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Transplantation, 10 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in Paul Salm's work include Renal Transplantation Outcomes and Treatments (25 papers), HIV/AIDS drug development and treatment (10 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Paul Salm is often cited by papers focused on Renal Transplantation Outcomes and Treatments (25 papers), HIV/AIDS drug development and treatment (10 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Paul Salm collaborates with scholars based in Australia, Switzerland and United Kingdom. Paul Salm's co-authors include Paul J. Taylor, Peter I. Pillans, J. Paul Taylor, Stephen V. Lynch, Susan E. Tett, Martine Bot, Martin F. Brodde, Volker Brinkmann, Darren M. Roberts and Gerd Assmann and has published in prestigious journals such as Circulation, Clinical Chemistry and Journal of Chromatography B.

In The Last Decade

Paul Salm

33 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Salm Australia 18 430 283 189 171 155 34 869
Karl‐Friedrich Sewing Germany 16 242 0.6× 151 0.5× 260 1.4× 81 0.5× 148 1.0× 25 726
Takafumi Kuzuya Japan 16 176 0.4× 155 0.5× 183 1.0× 154 0.9× 131 0.8× 43 716
W. Tetzloff Germany 10 152 0.4× 85 0.3× 72 0.4× 96 0.6× 165 1.1× 13 659
Elena Suárez Spain 14 62 0.1× 98 0.3× 90 0.5× 96 0.6× 148 1.0× 59 659
Paweł K. Kunicki Poland 10 125 0.3× 59 0.2× 46 0.2× 94 0.5× 53 0.3× 26 345
P W Lücker Germany 15 49 0.1× 276 1.0× 136 0.7× 188 1.1× 82 0.5× 45 969
Landry K. Kamdem United States 12 148 0.3× 162 0.6× 62 0.3× 59 0.3× 229 1.5× 21 898
Michael E. Franklin Australia 11 106 0.2× 86 0.3× 30 0.2× 63 0.4× 53 0.3× 14 543
Kiumars Vadiei United States 16 43 0.1× 118 0.4× 55 0.3× 62 0.4× 91 0.6× 26 588
Daisuke Teshima Japan 16 53 0.1× 141 0.5× 24 0.1× 85 0.5× 45 0.3× 44 539

Countries citing papers authored by Paul Salm

Since Specialization
Citations

This map shows the geographic impact of Paul Salm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Salm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Salm more than expected).

Fields of papers citing papers by Paul Salm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Salm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Salm. The network helps show where Paul Salm may publish in the future.

Co-authorship network of co-authors of Paul Salm

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Salm. A scholar is included among the top collaborators of Paul Salm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Salm. Paul Salm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
4.
Franklin, Michael E., Nigel W. Brown, J. Michael Tredger, et al.. (2007). The measurement of total and free mycophenolic acid by HPLC-Tandem mass spectrometry. Therapeutic Drug Monitoring. 29(4). 510–511. 1 indexed citations
5.
Westley, Ian S, Paul J. Taylor, Paul Salm, & Raymond G. Morris. (2007). Cloned Enzyme Donor Immunoassay Tacrolimus Assay Compared With High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Microparticle Enzyme Immunoassay in Liver and Renal Transplant Recipients. Therapeutic Drug Monitoring. 29(5). 584–591. 23 indexed citations
6.
Nofer, Jerzy–Roch, Martine Bot, Martin F. Brodde, et al.. (2007). FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice. Circulation. 115(4). 501–508. 187 indexed citations
7.
Morris, Raymond G., et al.. (2006). Comparison of the Reintroduced MEIA® Assay With HPLC-MS/MS for the Determination of Whole-Blood Sirolimus From Transplant Recipients. Therapeutic Drug Monitoring. 28(2). 164–168. 25 indexed citations
9.
Salm, Paul, et al.. (2005). A rapid HPLC-mass spectrometry cyclosporin method suitable for current monitoring practices. Clinical Biochemistry. 38(7). 667–673. 26 indexed citations
10.
Taylor, Paul J., et al.. (2005). Comparison Of The Re-introduced MEIA?? Sirolimus Assay With HPLC-MSMS In Renal Transplant Recipients. Therapeutic Drug Monitoring. 27(2). 236–237.
11.
Salm, Paul, Paul J. Taylor, Stephen V. Lynch, & Peter I. Pillans. (2002). Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography–electrospray tandem mass spectrometry. Journal of Chromatography B. 772(2). 283–290. 28 indexed citations
12.
Salm, Paul, et al.. (2001). A Detection Scheme for Paraquat Poisoning: Validation and a Five-Year Experience in Australia. Journal of Analytical Toxicology. 25(6). 456–460. 14 indexed citations
13.
Willis, Charlene, Paul J. Taylor, Paul Salm, Susan E. Tett, & Peter I. Pillans. (2000). Evaluation of Limited Sampling Strategies for Estimation of 12-Hour Mycophenolic Acid Area Under the Plasma Concentration???Time Curve in Adult Renal Transplant Patients. Therapeutic Drug Monitoring. 22(5). 549–554. 53 indexed citations
14.
Salm, Paul, et al.. (2000). Stability of Sirolimus (Rapamycin) in Whole Blood. Therapeutic Drug Monitoring. 22(4). 423–426. 13 indexed citations
16.
Taylor, J. Paul, Paul Salm, Stephen V. Lynch, & Peter I. Pillans. (2000). Simultaneous Quantification of Tacrolimus and Sirolimus, in Human Blood, by High-Performance Liquid Chromatography???Tandem Mass Spectrometry. Therapeutic Drug Monitoring. 22(5). 608–612. 41 indexed citations
17.
Willis, C., et al.. (1999). Evaluation of limited sampling strategies for the estimation of 12-hour Mycophenolic Acid. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
18.
Taylor, Paul J., Paul Salm, Ross Norris, Peter J. Ravenscroft, & Susan M. Pond. (1994). Comparison of High-Performance Liquid Chromatography and Monoclonal Fluorescence Polarization Immunoassay for the Determination of Whole-Blood Cyclosporin A in Liver and Heart Transplant Patients. Therapeutic Drug Monitoring. 16(5). 526–530. 8 indexed citations
19.
Salm, Paul, et al.. (1993). A Reliable High-Performance Liquid Chromatography Assay for High-Throughput Routine Cyclosporin A Monitoring in Whole Blood. Therapeutic Drug Monitoring. 15(1). 65–69. 19 indexed citations
20.
Taylor, J. Paul, B. G. Charles, Ross Norris, Paul Salm, & Peter J. Ravenscroft. (1992). Measurement of dothiepin and its major metabolites in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 581(1). 152–155. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026